Campaign details
Brand: Incite Country: UK
Synopsis
Background
Clearer understanding of physicians' prescribing behaviour is becoming increasingly important in conditions such as relapsed and refractory Multiple Myeloma (rrMM) where the market is highly competitive, saturated, and lacks head-to-head clinical tri